CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Human Metabolome Technologies Inc Company Snapshot
Human Metabolome Technologies Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Human Metabolome Technologies Inc with three other companies in this sector in Japan: Medinet Co., Ltd. (2018 sales of 998.28 million Japanese Yen [US$8.81 million] ), PhoenixBio Co Ltd (902.37 million Japanese Yen [US$7.97 million] ), and Gene Techno Science Co Ltd (1.06 billion Japanese Yen [US$9.36 million] of which 100% was Drug Development).

Sales Analysis. Human Metabolome Technologies Inc reported sales of ¥938.18 million (US$8.28 million) for the fiscal year ending March of 2018. This represents an increase of 2.6% versus 2017, when the company's sales were ¥914.18 million. Sales at Human Metabolome Technologies Inc have increased during each of the previous five years (and since 2013, sales have increased a total of 89%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Human Metabolome Technologies Inc
  Stock Performance Chart for Human Metabolome Technologies Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 1,320.00
(Figures in Japanese Yen)
1 Week -10.3%   13 Weeks -17.6%  
4 Weeks -23.5%   52 Weeks -33.5%  
 
Human Metabolome Technologies Inc Key Data:
  Ticker: 6090 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 938,178,000
(Year Ending Jan 2019).
Employees: 61
  Currency: Japanese Yen Market Cap: 7,723,011,120
  Fiscal Yr Ends: March Shares Outstanding: 5,850,766
  Share Type: Ordinary Closely Held Shares: 1,325,100
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.